Latigo Biotherapeutics, Inc. (NASDAQ:LTGO)
| Market Cap | $781.99M-28.8% |
| Revenue (ttm) | $0 |
| Net Income | -$107.29M |
| EPS | -$2.35 |
| Shares Out | 66.30M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 267,166 |
| Open | $13.22 |
| Previous Close | $13.24 |
| Day's Range | $11.91 - $13.35 |
| 52-Week Range | $10.24 - $25.93 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | $52.25(+301.92%) |
| Earnings Date | Mar 3, 2027 |
About LTGO
Latigo Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company committed to developing innovative non-opioid pain medicines designed to rapidly and effectively stop the transmission of pain without the risk of addiction. Its products include Molecule: LTG-001, Molecule: LTG-32, Molecule: LTG-001 IV and Molecule: LTG-418. The company was founded on November 20, 2018 and is headquartered in Thousand Oak, CA.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
When insiders bought and sold
1 year · open-market trades onlyNext catalysts
- Mar 3, 2027Earnings report
$LTGO stock is featured in our Insider Trades datasets.
→ All Stock ListsRecently reported changes in LTGO holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by LTGO's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
LTGO Estimated quarterly lobbying spending
Source: U.S. Senate LDA
LTGO Revenue by Segment
| Other clinical and non-clinical programs | $5.15M | 51.01% |
| Direct Program Costs Onzotrigine | $4.94M | 48.99% |
As of: Q3 2026 (Sep 30, 2026) · Source: SEC EDGAR (10-Q)
U.S. Patents
New LTGO patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to LTGO from public contracts
Source: USAspending.gov
Top ETF Holders
ETFs with the largest estimated holdings in LTGO
| VTIVanguard Morningstar Total Stock Market ETF | $6.92M |
| VXFVanguard Extended Market ETF | $3.03M |
| SCHASchwab U.S. Small-Cap ETF | $1.28M |
| SCHBSchwab U.S. Broad Market ETF | $153.37K |
| VTWOVanguard Russell 2000 ETF | $110.41K |
| VTWGVanguard Russell 2000 Growth ETF | $11.02K |
Estimated from each fund’s disclosed top holdings × AUM
Bull Case vs Bear Case
AI-generated from LTGO’s recent data — informational, not investment advice
